Hikma Pharmaceuticals PLC
HIK · LSE
Public Market Listing
Live quotes, historical charts, and market capitalization for Hikma Pharmaceuticals PLC are available on Yahoo Finance.
View quote & market cap on Yahoo Finance ↗External market data link · No third-party exchange redistribution
Assets
(3 total)
| Target & Modality | |||
|---|---|---|---|
Cenobamate(Xcopri) | Approved | Sodium channels + GABA-A receptorsSmall molecule | Epilepsy Focal Onset Seizures |
| Approved | GABA-A receptorSmall molecule | Epilepsy | |
| Approved | IL-12 p40Monoclonal antibody | Inflammatory Bowel DiseasePsoriatic ArthritisPsoriasis Ulcerative Colitis, Crohn's Disease |
Upcoming events
(3 total)
Estimated primary-completion dates from ClinicalTrials.gov and expected earnings reports. These are registry estimates, never confirmed readout dates; they can move as trials progress.
Add these trial readouts to your calendar: Apple or Outlook · Google Calendar · .ics link. The calendar updates when a registry date moves.
Regulatory and conference events
(4)
Filings, regulator decisions, scientific presentations, topline results and licensing deals, each from a dated source. When a source gives only the month, the month is shown.
Coming up
Recent